DCF Valuation
Updated: 2026-07-22, aligned to Rōvn master canon generation 8 (effective 2026-07-21).
The prior DCF is withdrawn. It was computed from the dated May 2026 three-case model, which was built on a retired internal price ladder. A discounted-cash-flow figure derived from withdrawn projections is not diligence-grade, so this room does not publish one.
How Rōvn talks about valuation
- Fundraising is milestone-based. The intended real round is a post-Demo-Day seed, currently modeled at roughly $5M, sized against actual proof, burn, and the NCQA-CVO certification path. If YC says no, the company raises an independent lean pre-seed against the same milestones.
- Round amount, valuation, exemption, and final terms remain CEO, board, and counsel decisions. Terms stay silent until counsel confirms the offering exemption. No cap or valuation is published here.
- Any external valuation scenario requires a comparables memo that defines the reachable revenue pools, shows the network and margin mechanics, separates healthcare from later expansion, uses time-stamped public comparables, and discounts execution, legal, and platform risk. That memo does not exist yet, so no scenario is quoted.
- Long-term ceiling scenarios in company planning are internal aspirations, not forecasts, and do not appear in this room as numbers.
For the evidence an investor can price today, see 02.3 Revenue Model (honest three-case discipline, zero contracted revenue), 02.5 Comparable Multiples (verified transactions and the honest limits of inference), and 02.1 Use of Funds (the financing sequence and the six checkable provables).